Prospective HemorrhoIdaL EmboliSation (PILES) Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJoint & Vascular Institute

About this trial

The goal of this observational study (prospective registry) is to collect long-term real-world data on the effectiveness and safety of hemorrhoid artery embolization (HAE) for symptomatic bleeding internal hemorrhoids in adults aged 18 years or older that have not responded to medical therapy.

The main question it aims to answer are:

1\) Does HAE lead to sustained improvement in bleeding (HDSS scores over 12-36 months?

Participants will:

* Undergo HAE as part of their routine clinical care. * Complete clinical follow-up assessments at 1, 3, 6, 12, 18, 24, and 36 months after treatment, including symptom and quality-of-life questionnaires. * Have safety outcomes tracked according to Society of Interventional Radiology guidelines.

There is no comparison group; results will be analyzed to identify predictors of success and inform best practices for patient selection and treatment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults (≥18 years) with symptomatic bleeding internal hemorrhoids refractory to medical therapy, referred for HAE.

Disqualifiers

Pregnancy, coagulopathy, severe comorbidities, or inability to consent.

Trial population

The study population consists of adult patients (18 years and older) presenting to the Joint \& Vascular Institute for clinical consultation regarding symptomatic internal hemorrhoids. This population includes individuals who have failed standard medical management (such as dietary modifications, topical therapies, or office-based procedures) and are seeking minimally invasive alternatives to surgical hemorrhoidectomy. The registry will include men and women of all races and ethnicities without exclusion, provided they meet the clinical criteria for Hemorrhoidal Artery Embolization (HAE) as determined by the Principal Investigator or Sub-Investigators.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Hemorrhoid Artery Embolization

    Procedure/Surgery

    Hemorrhoidal Artery Embolization (HAE)-often referred to clinically as the Emborrhoid technique-is a minimally invasive, image-guided procedure in which embolic agents are delivered into the superior rectal arteries to reduce hypervascular blood flow, thereby shrinking engorged hemorrhoidal plexuses and alleviating chronic bleeding and discomfort from internal hemorrhoids.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Hemorrhoidal Disease Symptom Score (HDSS)

Time frame
5 years of enrollment/patient

Secondary outcomes

1

Short Health Scale for hemorrhoidal disease (SHSHD)

Time frame
5 years of enrollment/patient
2

French Bleeding Score (FBS)

Time frame
5 years of enrollment/patient

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.